XML 23 R8.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings (Accumulated Deficit)
Beginning balance (in shares) at Mar. 31, 2019 76,249,000        
Beginning balance at Mar. 31, 2019 $ 81,433        
Increase (Decrease) in Temporary Equity [Roll Forward]          
Exercise of Series B redeemable convertible preferred stock warrants (in shares) 38,000        
Exercise of Series B redeemable convertible preferred stock warrants $ 25        
Ending balance (in shares) at Mar. 31, 2020 76,287,000        
Ending balance at Mar. 31, 2020 $ 81,458        
Beginning balance (in shares) at Mar. 31, 2019   65,526,000      
Beginning balance at Mar. 31, 2019 (32,935) $ 65 $ 10,623 $ 0 $ (43,623)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 2,537   2,537    
Exercise of stock options (in shares)   3,040,000      
Exercise of stock options 1,694 $ 3 1,691    
Common stock warrant expense 57   57    
Other comprehensive loss 0        
Exercise of Series B redeemable convertible preferred stock warrants 46   46    
Net income 29,737       29,737
Ending balance (in shares) at Mar. 31, 2020   68,566,000      
Ending balance at Mar. 31, 2020 $ 1,136 $ 68 14,954 0 (13,886)
Ending balance (in shares) at Mar. 31, 2021 76,287,000        
Ending balance at Mar. 31, 2021 $ 81,458        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 7,398   7,398    
Exercise of stock options (in shares)   13,890,000      
Exercise of stock options 8,897 $ 14 8,883    
Issuance of common stock in exchange for services (in shares)   22,000      
Issuance of common stock in exchange for services 34   34    
Repurchase and retirement of common stock (in shares)   (258,000)      
Repurchase and retirement of common stock (2,022)   (2,022)    
Common stock warrant expense 49   49    
Other comprehensive loss (21)     (21)  
Issuance of common stock in connection with an acquisition (in shares)   690,000      
Issuance of common stock in connection with an acquisition 1,062 $ 1 1,061    
Net income 50,210       50,210
Ending balance (in shares) at Mar. 31, 2021   82,910,000      
Ending balance at Mar. 31, 2021 $ 66,743 $ 83 30,357 (21) 36,324
Increase (Decrease) in Temporary Equity [Roll Forward]          
Conversion of redeemable convertible preferred stock upon initial public offering (in shares) (76,287,000)        
Conversion of redeemable convertible preferred stock upon initial public offering $ (81,458)        
Ending balance (in shares) at Mar. 31, 2022 0        
Ending balance at Mar. 31, 2022 $ 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation $ 29,341   29,341    
Exercise of stock options (in shares) 10,823,000 10,823,000      
Exercise of stock options $ 12,612 $ 11 12,601    
Vesting of restricted stock units (in shares)   24,000      
Tax withholding on shares under stock-based compensation awards (817)   (817)    
Repurchase and retirement of common stock (in shares)   (181,000)      
Repurchase and retirement of common stock (2,698)   (2,698)    
Common stock warrant expense 2,598   2,598    
Other comprehensive loss (15,273)     (15,273)  
Conversion of redeemable convertible preferred stock upon initial public offering (in shares)   76,287,000      
Conversion of redeemable convertible preferred stock upon initial public offering 81,458 $ 76 81,382    
Issuance of common stock upon initial public offering, net of underwriting discounts and commissions and deferred offering costs (in shares)   22,506,000      
Issuance of common stock upon initial public offering, net of underwriting discounts and commissions and deferred offering costs 548,452 $ 22 548,430    
Issuance of common stock in connection with the employee stock purchase plan (in shares)   29,000      
Issuance of common stock in connection with the employee stock purchase plan 1,395   1,395    
Net income 154,783       154,783
Ending balance (in shares) at Mar. 31, 2022   192,398,000      
Ending balance at Mar. 31, 2022 $ 878,594 $ 192 $ 702,589 $ (15,294) $ 191,107